COMPOUNDS EFFECTING GLUCOKINASE
Application 118/MUMNP/2004 published 2006-02-03, filed 2004-02-16
The invention relates to the use of a compound of Formula (I) or a salt, solvate or prodrug thereof, wherein R1, R2, R3, n and m are as described in the specification, in the preparation of a medicament for the treatment or prevention of a disease condition mediated through glucokinase (GLK), such as type 2 diabetes. The invention also relates to a novel group of compounds of Formula (I) and to methods for preparing compounds of Formula (I). Drawing NIL Sheets. Total Pages: 150
Applicant
ASTRAZENECA AB
S-151 SODERTAIJE, SWEDEN
Inventor
1. SCOTT BOYD 2. PETER WILLIAM RODNEY CAULKETT 3. RODNEY BRIAN HARGREAVES 4. SUZANNE SAXON BOWKER 5. ROGER JAMES 6. CRAIG JOHNSTONE 7. CLIFFORD DAVID JONES 8. DARREN MCKERRECHER 9. MICHAEL HOWARD BLOCK
International Info
Classification: A61K 31/425
Publication Number: WO 03/015774 A1
Application Date: 2002-08-15
Priority Information
0102764-8 SWEDEN 2001-08-17